Theratechnologies (TSX:TH) EBIT per Share : C$0.24 (TTM As of Aug. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Theratechnologies EBIT per Share?

Theratechnologies's EBIT per Share for the three months ended in Aug. 2024 was C$0.18. Its EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2024 was C$0.24.

During the past 3 years, the average EBIT per Share Growth Rate was 23.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was -26.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Theratechnologies's EBIT per Share or its related term are showing as below:

TSX:TH' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -82.7 Med: -1.8 Max: 44.1
Current: 23.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Theratechnologies was 44.10% per year. The lowest was -82.70% per year. And the median was -1.80% per year.

TSX:TH's 3-Year EBIT Growth Rate is ranked better than
75.74% of 1249 companies
in the Biotechnology industry
Industry Median: 2.8 vs TSX:TH: 23.20

Theratechnologies's EBIT for the three months ended in Aug. 2024 was C$8.9 Mil.

Theratechnologies EBIT per Share Historical Data

The historical data trend for Theratechnologies's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies EBIT per Share Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

EBIT per Share

Get a 7-Day Free Trial

-0.52

-1.17

-1.42

-2.28

-0.69

Theratechnologies Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
EBIT per Share	Get a 7-Day Free Trial															0.12	0.01	-0.05	0.11	0.18

Theratechnologies EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Theratechnologies's EBIT per Share for the fiscal year that ended in Nov. 2023 is calculated as

	EBIT per Share		(A: Nov. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-18.059	/	26.332
=	-0.69

Theratechnologies's EBIT per Share for the quarter that ended in Aug. 2024 is calculated as

	EBIT per Share		(Q: Aug. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	8.887	/	49.373
=	0.18

EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.24

Theratechnologies (TSX:TH) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Theratechnologies EBIT per Share Related Terms

Thank you for viewing the detailed overview of Theratechnologies's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

THTX:USA TQ80:Germany TQ80:Germany

Address

2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Executives

Dale Weil	Director
Joseph Arena	Director
Philippe Dubuc	Senior Officer
Gérald A. Lacoste	Director
Paul Lévesque	Senior Officer
Andrew Molson	Director
Dawn Svoronos	Director
John Leasure	Senior Officer
Alain Trudeau	Director
Sheila Frame	Director
Gary Peter Littlejohn	Director
Marie-noël Colussi	Senior Officer
Jovan Antunovic	Senior Officer
Christian Marsolais	Senior Officer
Jocelyn Lafond	Senior Officer